The management of haemoglobinopathies
Abstract
Sickle cell disease (SCD) and thalassaemia major are the most important syndromes of the haemoglobinopathies. Complications of SCD can be life threatening and include stroke, hyposplenism and vaso-occlusive crises. Treatment of SCD is generally supportive or by transfusion, hydroxyurea or bone marrow transplant (BMT). β Thalassaemia major is treated with transfusion and chelation for the resulting iron overload which is the cause of most morbidity, with BMT the only curative procedure.
Keywords: haemoglobinopathies, Sickle cell, thalassaemia, Clinical Management, transfusion, hydroxyurea
No full text is available. To read the body of this article, please view the PDF online.
To access this article, please choose from the options below
PII: S0957-5839(02)90301-5
doi:10.1054/cupe.2002.0301
© 2002 Elsevier Science Ltd. All rights reserved.

